- World rank, all time
- #24,499 of 42,892
- Rank in Spain
- #584 of 927
- Research works
- 184 ▲ 30% vs 2013–17
- Citations
- 5.1k 27.5 per fractional work
- Top-10% rate
- 11.7% record average 16.5%
- Open access
- 51% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.1×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.1×
- Immunology and Microbiology 3.9×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 2.3×
- Materials Science 1.7×
- Neuroscience 0.6×
- Dentistry 0.5×
- Chemistry 0.4×
- Engineering 0.3×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.3×
- Nursing 0.2×
- Economics, Econometrics and Finance 0.2×
- Physics and Astronomy 0.2×
- Environmental Science 0.2×
- Health Professions 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Mathematics 0.1×
Which keywords describe research at CIBBIM-Nanomedicine?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Tumor Microenvironment, Cancer, Cancer Therapy, Targeted Therapy, Drug Delivery and Nanoparticles.
- Surface Engineering
- Radiomics
- Metastatic Breast Cancer
- Photothermal Therapy
- Fluorouracil
- Clinical Trials
- Molecular Characterization
- Immunity
- Photodynamic Therapy
- Cetuximab
- Neoadjuvant Therapy
- Molecular Subtypes
- Tumor Targeting
- Cancer Genomics
- Immune Checkpoint Blockade
- Precision Medicine
- Drug Delivery
- Nanoparticles
- Tumor Microenvironment
- Chemotherapy
- Immunotherapy
- Cancer
- Cancer Therapy
- Targeted Therapy
- Biomedical Applications
- Genomic Instability
- PD-1 and PD-L1
- Mutational Signatures
- Radiotherapy
- Biomarkers
- Breast Cancer
- Cancer Immunotherapy
- Prognostic Factors
- Medical Imaging
- BRAF Mutation
- Predictive Modeling
- KRAS Mutations
- Cell Death
- Quantitative Analysis
- Nanocarriers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy5▲ 15×11 topics
- Chemotherapy4▲ 14×15 topics
- Cancer4▲ 6.8×22 topics
- Tumor Microenvironment4▲ 20×6 topics
- Cancer Therapy4▲ 14×10 topics
- Nanoparticles3▲ 6.0×10 topics
- Targeted Therapy3▲ 34×4 topics
- Drug Delivery3▲ 13×9 topics
- Biomedical Applications3▲ 5.7×11 topics
- Precision Medicine3▲ 13×6 topics
- Genomic Instability3▲ 55×3 topics
- Immune Checkpoint Blockade3▲ 54×1 topic
- PD-1 and PD-L13▲ 54×1 topic
- Cancer Genomics2▲ 76×1 topic
- Mutational Signatures2▲ 76×1 topic
- Tumor Targeting2▲ 31×3 topics
- Radiotherapy2▲ 13×6 topics
- Molecular Subtypes2▲ 50×3 topics
- Biomarkers2▲ 5.7×8 topics
- Neoadjuvant Therapy2▲ 17×5 topics
- Breast Cancer2▲ 16×7 topics
- Cetuximab2▲ 45×2 topics
- Cancer Immunotherapy2▲ 23×2 topics
- Photodynamic Therapy2▲ 16×3 topics
- Prognostic Factors2▲ 7.9×7 topics
- Immunity2▲ 8.1×5 topics
- Medical Imaging2▲ 6.3×4 topics
- Molecular Characterization2▲ 19×4 topics
- BRAF Mutation1▲ 44×2 topics
- Clinical Trials1▲ 4.7×7 topics
- Predictive Modeling1▲ 11×2 topics
- Fluorouracil1▲ 87×1 topic
- KRAS Mutations1▲ 87×1 topic
- Photothermal Therapy1▲ 22×2 topics
- Cell Death1▲ 11×5 topics
- Metastatic Breast Cancer1▲ 46×2 topics
- Quantitative Analysis1▲ 13×1 topic
- Radiomics1▲ 22×1 topic
- Nanocarriers1▲ 45×1 topic
- Surface Engineering1▲ 27×1 topic
Which research topics does CIBBIM-Nanomedicine publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 2 Cancer Genomics and Diagnostics Cancer Research 2 works
- 3 Colorectal Cancer Treatments and Studies Oncology 1 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
- 5 Nanoparticle-Based Drug Delivery Biomaterials 1 works
- 6 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
- 7 Glioma Diagnosis and Treatment Genetics 1 works
- 8 Immunotherapy and Immune Responses Immunology 1 works
- 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 1 works
- 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CIBBIM-Nanomedicine's research output changed?
Output in 2018–2022 was 30% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.